Technology Begins to Replace Human Communication in Clinical Trial Management

DENVER, Sept. 6, 2017 /PRNewswire/ -- ClinOne is a mobile clinical trial management platform that accelerates clinical trial engagement, recruitment, and management by nearly two-fold. A component of the technology suite is providing open research sites dynamic real-time communication, which in the past failed to meet the need for augment clinical trial performance.

Here are the facts – when your study has 200 sites globally, you're most likely trying to communicate to 10 or more personnel at each site, sometime as many as 20. Therefore on a weekly basis, you're seeking to send 3,000 emails or make 200 phone calls. The cost of these­­­ communications through your CRA is immense – approximately 30 minutes for an email and maybe 15 minutes for a phone call. At an hourly rate of $125 an hour, the basic cost of these communication is $19,000 a month. More than 90% of trials simply cannot meet these communication expectations. Imagine that you're a highly active a sponsor in site communication, you can easily double or triple the cost, according to Rob Bohacs, ClinOne's CEO. For a fraction of that cost, our technology emails and sends mobile push notifications, with the option of text notifications coming in the near future. Emails are read in 5.5 hours on average and push notifications/text message are read in 4 minutes.  

According to Mr. Bohacs, "If you look at the world around us, Facebook, LinkedIn, Twitter for example, these companies don't utilize CRAs or phone calls for updates and notifications, there mastered how technology can keep everyone connected and engaged. We now rely on technology keeping us apprised of critical updates around us. Similarly to our (ClinOnes) technology, we monitor digital engagement of each site user and our system communicates differently based on how the sites are utilizing our technology."

About ClinOne, Inc.

Based in Denver, Colorado, ClinOne is a mobile technology company dedicated to transitioning research into a mobile environment to significantly improve how researchers and patients interact and engage with clinical trials. The company offers a full suite of mobile technologies to centralize research and deliver the needed clinical trial content to the right participants. ClinOne information platform aims to improve day-to-day engagement of clinicians, academic researchers, drug developers, and patients to help advance drug and medical device clinical trials.

For more information, please visit www.ClinOne.com.

SOURCE ClinOne, Inc.

Related Links

http://www.ClinOne.com